Shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Get Rating) have earned an average rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $59.83.
Several equities analysts have weighed in on KIDS shares. Truist Financial dropped their price target on OrthoPediatrics to $51.00 in a research report on Friday, July 22nd. BTIG Research dropped their price target on OrthoPediatrics from $65.00 to $61.00 and set a “buy” rating for the company in a research report on Monday, July 18th. Stifel Nicolaus dropped their price target on OrthoPediatrics from $57.00 to $50.00 in a research report on Monday, July 18th. Piper Sandler dropped their price target on OrthoPediatrics from $80.00 to $55.00 in a research report on Thursday, May 5th. Finally, TheStreet downgraded OrthoPediatrics from a “c” rating to a “d+” rating in a research report on Thursday, May 5th.
Insider Transactions at OrthoPediatrics
In other OrthoPediatrics news, Director Harold Ruf acquired 1,235 shares of the firm’s stock in a transaction dated Thursday, June 16th. The shares were acquired at an average price of $39.45 per share, for a total transaction of $48,720.75. Following the completion of the acquisition, the director now directly owns 13,824 shares of the company’s stock, valued at $545,356.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 29.50% of the company’s stock.
Institutional Inflows and Outflows
OrthoPediatrics Price Performance
NASDAQ KIDS opened at $49.20 on Thursday. OrthoPediatrics has a 1-year low of $36.71 and a 1-year high of $73.91. The company has a market capitalization of $995.32 million, a P/E ratio of -63.90 and a beta of 0.88. The business has a 50 day moving average price of $44.29 and a 200 day moving average price of $47.36.
OrthoPediatrics (NASDAQ:KIDS – Get Rating) last released its quarterly earnings data on Wednesday, May 4th. The company reported ($0.30) earnings per share for the quarter, meeting the consensus estimate of ($0.30). The firm had revenue of $23.42 million during the quarter, compared to the consensus estimate of $22.70 million. OrthoPediatrics had a negative return on equity of 7.04% and a negative net margin of 14.98%. On average, research analysts expect that OrthoPediatrics will post -0.8 earnings per share for the current fiscal year.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
- Get a free copy of the StockNews.com research report on OrthoPediatrics (KIDS)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn’t Ignore
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.